Less Influence for High-Impact Journals

A new study reveals that more and more of the world’s most-cited articles are published outside of high prestige, high impact factor journals.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Wikimedia, VmenkovThe influence of high-impact factor journals is declining, according to a study published this week (November 7) in the Journal of the American Society for Information Science and Technology. The findings raise questions over the relationship between the impact-factor—the current best measure of a publication’s influence—and the number of citations subsequently received by papers published in that journal.

Analyzing a sample of around 820 million citations in 25 million articles published between 1990 and 2009, researchers at the University of Montreal found that the proportion of the world’s most-cited articles published in traditional powerhouse journals like Nature, Science, Cell, and the Journal of the American Medical Association (JAMA) has sharply declined over the past 2 decades. In 1990, nearly half of the top 5 percent of articles—those that received most citations over the following 2 years—were published in the top 5 percent highest impact factor journals. But by 2009 that rate was down to 36 percent, meaning today’s most-cited articles are found less exclusively in high-impact factor journals.

The authors suggest the decline can be attributed to how the Internet has transformed the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA